VC
Viswanath Chebrol
About Viswanath Chebrol
Data last updated:
Viswanath Chebrol is a Director at Gland Chemicals Pvt Ltd (since 2022), Director at Gcbc Vaccines Private Limited (since 2024) and Director at Sagent Pharma Services (India) Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma, Wood and Outsourcing. The largest current company by reported revenue is Gland Chemicals Pvt Ltd at ₹401 Cr (FY 2022). Earlier, Viswanath Chebrol was a Director at Healthium Medtech Limited (2010–2012) and Additional Director at Symbiotec Pharmalab Limited (2018–2019) and 9 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gland Chemicals Pvt Ltd U24110TG1974PTC001694 | Director | 14 Nov 2022 | 1974 | ₹401 Cr (FY 2022) | Active |
| Gcbc Vaccines Private Limited U20299TS2023PTC178588 | Director | 20 Jun 2024 | 2023 | Active | |
| Sagent Pharma Services (India) Private Limited U62099TS2023FTC175890 | Director | 09 Aug 2023 | 2023 | Active | |
| Parami Advisory Partners Llp ABC-5802 | Designated Partner | 29 Sep 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Healthium Medtech Limited U03311KA1992PLC013831 | Director | 25 Aug 2010 | 1992 | ₹870 Cr (FY 2025) | Active |
 Symbiotec Pharmalab Limited U24232MP2002PLC015293 | Additional Director | 06 Dec 2018 | 2002 | ₹756 Cr (FY 2025) | Active |
 Biorad Medisys Private Limited U33111MH2000PTC265335 | Director | 04 Feb 2016 | 2000 | ₹557 Cr (FY 2025) | Active |
 Sandor Medicaids Private Limited U51101TG1995PTC021906 | Director | 08 Jan 2016 | 1995 | ₹107 Cr (FY 2023) | Active |
 Neuland Health Sciences Private Limited U73100TG1993PTC015554 | Director | 02 Aug 2013 | 1993 | ₹580 Cr (FY 2017) | Amalgamated |
| Neuland Pharma Research Private Limited U73100TG2012PTC080474 | Alternate Director | 07 Dec 2012 | 2012 | ₹61.52 Cr (FY 2017) | Amalgamated |
 Invascent Advisory Services India Private Limited U74140TG2006PTC050912 | Director | 13 Jul 2007 | 2006 | ₹15.58 Cr (FY 2020) | Converted To Llp |
 Relisys Medical Devices Limited U85101TG1997PLC028153 | Nominee Director | 24 Oct 2014 | 1997 | ₹214 Cr (FY 2025) | Active |
| Easystich Needles Private Limited U24236KA1995PTC019479 | Additional Director | 24 Aug 2009 | 1995 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Viswanath Chebrol
| Name | DIN | Company | Designation |
|---|---|---|---|
| Naga Malleswara Rao Bandreddi | 01282921 | Gland Chemicals Pvt Ltd | Managing Director |
| Nakul Venkat Penmetsa | 06446869 | Gland Chemicals Pvt Ltd | Director |
| Penmetsa Ravindranath | 00179939 | Gland Chemicals Pvt Ltd , Gcbc Vaccines Private Limited and 1 more | Director |
| Ramesh Kumar Penmetcha | 01198019 | Gland Chemicals Pvt Ltd | Director |
| Dosapati Sai Venkat Raman Rao | 02417970 | Gcbc Vaccines Private Limited | Director |
| Koduru Iswara Varaprasad Reddy | 00196148 | Gcbc Vaccines Private Limited | Director |
| Radha Krishnam Raju Mantena | 10456043 | Gcbc Vaccines Private Limited | Director |
| Jeffrey William Greve | 10273523 | Sagent Pharma Services (India) Private Limited | Non- Individual Subscriber |
| Prakash Vithal Baliga | 10850033 | Sagent Pharma Services (India) Private Limited | Additional Director |
| Venkata Sashikanth Pochimcharla | 10273524 | Sagent Pharma Services (India) Private Limited | Director |
| Venkata Gautham Chitrapu | 05226248 | Parami Advisory Partners Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Viswanath Chebrol
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viswanath Chebrol
Viswanath Chebrol currently holds 4 directorships: Gland Chemicals Pvt Ltd (Director, since 14 Nov 2022, revenue ₹401 Cr (FY 2022)); Gcbc Vaccines Private Limited (Director, since 20 Jun 2024); Sagent Pharma Services (India) Private Limited (Director, since 09 Aug 2023); Parami Advisory Partners Llp (Designated Partner, since 29 Sep 2022).
Viswanath Chebrol was first appointed on 13 Jul 2007 as Director at Invascent Advisory Services India Private Limited. The most recent appointment on record is 20 Jun 2024 at Gcbc Vaccines Private Limited.
Viswanath Chebrol held 11 earlier board appointments: Healthium Medtech Limited (Director, 25 Aug 2010 to 08 Oct 2012); Symbiotec Pharmalab Limited (Additional Director, 06 Dec 2018 to 24 Sep 2019); Biorad Medisys Private Limited (Director, 04 Feb 2016 to 20 Mar 2023); Sandor Medicaids Private Limited (Director, 08 Jan 2016 to 09 Jun 2024); Neuland Health Sciences Private Limited (Director, 02 Aug 2013 to 22 Jun 2017); and 6 more.
The current boards of Viswanath Chebrol's companies include Naga Malleswara Rao Bandreddi (Gland Chemicals Pvt Ltd), Nakul Venkat Penmetsa (Gland Chemicals Pvt Ltd), Penmetsa Ravindranath (Gland Chemicals Pvt Ltd), Ramesh Kumar Penmetcha (Gland Chemicals Pvt Ltd), Dosapati Sai Venkat Raman Rao (Gcbc Vaccines Private Limited), Koduru Iswara Varaprasad Reddy (Gcbc Vaccines Private Limited), among others.